- Home
- LXU vs RGNX Comparison
LXU vs RGNX Comparison
Compare LXU & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- RGNX
- Stock Information
- Founded
- LXU 1968
- RGNX 2008
- Country
- LXU United States
- RGNX United States
- Employees
- LXU N/A
- RGNX N/A
- Industry
- LXU Major Chemicals
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LXU Industrials
- RGNX Health Care
- Exchange
- LXU Nasdaq
- RGNX Nasdaq
- Market Cap
- LXU 612.4M
- RGNX 661.2M
- IPO Year
- LXU 1969
- RGNX 2015
- Fundamental
- Price
- LXU $8.43
- RGNX $12.77
- Analyst Decision
- LXU Buy
- RGNX Strong Buy
- Analyst Count
- LXU 3
- RGNX 7
- Target Price
- LXU $10.17
- RGNX $30.00
- AVG Volume (30 Days)
- LXU 432.6K
- RGNX 601.4K
- Earning Date
- LXU 10-29-2025
- RGNX 11-06-2025
- Dividend Yield
- LXU N/A
- RGNX N/A
- EPS Growth
- LXU N/A
- RGNX N/A
- EPS
- LXU N/A
- RGNX N/A
- Revenue
- LXU $585,065,000.00
- RGNX $155,782,000.00
- Revenue This Year
- LXU $12.10
- RGNX $198.02
- Revenue Next Year
- LXU N/A
- RGNX $2.67
- P/E Ratio
- LXU N/A
- RGNX N/A
- Revenue Growth
- LXU 12.49
- RGNX 74.95
- 52 Week Low
- LXU $4.88
- RGNX $5.04
- 52 Week High
- LXU $9.85
- RGNX $13.93
- Technical
- Relative Strength Index (RSI)
- LXU 46.30
- RGNX 58.75
- Support Level
- LXU $8.21
- RGNX $12.66
- Resistance Level
- LXU $9.85
- RGNX $13.93
- Average True Range (ATR)
- LXU 0.45
- RGNX 0.72
- MACD
- LXU -0.05
- RGNX -0.04
- Stochastic Oscillator
- LXU 13.41
- RGNX 61.82
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.